StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alder BioPharma (ALDR) is Janus Capital's Top M&A Biotech Pick - Bloomberg
May 2, 2016 3:40 PM
(Updated)Janus Capital's Andy Acker said in a Bloomberg Interview that Alder ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hedge Funds
Rumors
Trader Talk